Robb Gary Charles

SEC Form 4 insider
Chief Business Officer · CORCEPT THERAPEUTICS INC ($CORT)
1 thesis · first seen Aug 14, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d1100%+0.8%+0.8%
3d1100%+3.5%+3.5%
1w1100%+4.6%+4.6%
1m111100%-2.7%-2.7%
3m000———
6m000———
1y000———

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$CORTSEC Form 4bearish
Sold 10,000 @ $116.26 avg · $1,162,572 · 2026-08-17

Form 4: Robb Gary Charles sold CORT

Robb Gary Charles (Chief Business Officer at CORCEPT THERAPEUTICS INC) reported an open-market sale of 10,000 shares of CORT at an average $116.26, roughly $1,162,572, in a Form 4 filed 2026-08-18.

At post $118.10Now $122.25+3.5% since postedas of Aug 24, 1:28 PM ET
1d+0.8%
3d+3.5%
1w+4.6%
1m-2.7%
3m—
6m—
1y—
View filing on SEC.gov →

End of results.